Previous studies (18, 19) have shown that the inflammatory response produced in the rabbit eye by intravitreally injected Neisseria meningitidis or its stable L-phase variant was predominantly polymorphonuclear (during its initial phases) and gradually became mononuclear. No overt meningococcal infection was established and the eyes appeared clinically normal within 2 to 3 weeks. Specific antimeningococcal antibody was not demonstrated in the serum or ocular fluids of most rabbits.
The presence of large numbers of inflammatory cells in the eye and its relatively isolated position suggested that the inflamed eye might be used for in vivo studies on nonspecific resistance to infection. This paper presents observations on the effect of a previous injection of meningococci on the response to intravitreal injection of Diplococcus pneumoniae. The pneumococcus produces severe intraocular infection when injected intravitreally and is known to be phagocytized primarily by polymorphonuclear phagocytes. The possible mechanisms for the nonspecific resistance are discussed.
MATERIALS AND METHODS
Intravitreal injections. Fifty-six New Zealand white rabbits weighing approximately 2 kg were injected in the right vitreous with N. meningitidis. The procedures for preparing the organisms and for the intravitreal injections were as previously described (18) . Approximately 104 meningococci were injected into the right eye of each rabbit.
The strain of D. pneumoniae used in these experiments was a type 23, initially isolated from the eye of a human patient with shrinkage of the conjunctival sac. The lyophilized organisms were reconstituted and plated on sheep blood agar 24 h prior to challenge. Washed pneumococci were suspended in Hanks balanced salt solution (HBSS), and the concentration was adjusted so that each eye would receive approximately 1,000 to 3,000 organisms. The actual number of organisms injected was determined by plating dilutions of the suspension on blood agar.
Both eyes of six groups of rabbits were challenged with the pneumococci. The right eyes of these rabbits had been injected intravitreally with meningococci 2, 4, 6, 9, 14, or 22 days previously. At least two rabbits from each group were sacrificed at 24, 48, and 72 h and at 7 days after the injection of the pneumococci.
Recovery of pneumococci. The procedures used for recovery of the pneumococci were essentially the same as those used for recovering meningococci (18) . However, the diluted vitreous humor was plated on blood agar rather than on Mueller-Hinton agar. A separate pipette was used for each dilution step in these recovery experiments.
Treatment with nitrogen mustard. One group of eight rabbits was treated with nitrogen mustard prior to injection of the meningococci. The nitrogen mustard (NH2) (Mustargen, mechlorethamine hydrochloride; Merck, Sharp and Dohme) was injected intravenously at a dose of 0.75 mg/lb. The number of leukocytes in peripheral blood was determined from day 0 until the rabbits were killed. The nitrogen mustard injections were given on days 0, 2, and 6 of the experiment. The meningococci were injected into the right eyes of the rabbits on day 4, and the pneumococci were injected into both eyes on day 8 (4 days after meningococci). Four rabbits were killed at Antibody determinations. Sera from 56 rabbits were tested for antimeningococcal antibody by passive hemagglutination and bacterial agglutination methods described previously (18 Challenge on day 9. Some protection was noted in the three rabbits sacrificed at 24 h and in the four rabbits sacrificed at 48 h (Table 1) . Few viable pneumococci were recovered from four of seven right eyes, and in the other three rabbits there was a 10-to 100-fold difference between the number of organisms recovered from right and left eyes. The recovery after 72 h in this group was variable, and little protection was noted.
Challenge on days 14 and 22. The protective effect in the seven rabbits in these two groups was negligible. In many cases pneumococci multiplied as well in right eyes as in left eyes.
Recovery of pneumococci from nitrogen mustard-treated rabbits. The nitrogen mustard injection schedule was designed to produce profound leucopenia at the time the right eyes were injected with meningococci. The average leukocyte count at the time of the meningococci injection was 943/ml of blood (range, 550 to 1,250), and the average count at the time of the injection of the pneumococci (4 days later) was 1,081 per ml (300 to 3,050). The average number pretreatment was 12,375/ml. Figure 1 shows the average number of organisms recovered from the right and left eyes of treated rabbits compared with the numbers recovered from control rabbits challenged 4 days after the injection of meningococci. The lack of protection in the nitrogen mustardtreated group is evident.
Clinical manifestations. Almost all of the eyes showed severe iritis and conjunctivitis. Many of the left eyes were swollen shut, and the inflammation was accompanied by a whitish discharge. The right eyes were somewhat less severely inflamed.
Examination of vitreous smears. Numerous inflammatory cells, predominantly polymorphonuclear leukocytes (PMN), were observed in the vitreous smears from both right and left eyes. Gram-positive extracellular diplococci were seen in smears from left eyes and in some of the right eyes. Occasional intracellular diplococci and rare meningococci were found in the material from some right eyes.
The right eye smears from the nitrogen mustard-treated rabbits showed the presence of gram-positive diplococci and a small number of inflammatory cells, mostly mononuclear. More inflammatory cells and many organisms were observed in the left eyes.
Examination of stained sections. Both right and left eyes of the challenged rabbits showed mild to severe inflammation in the vitreous, retina, choroid, limbus, and anterior uvea. In- Right and left eyes of the nitrogen mustardtreated rabbits showed only a minimal inflammatory reaction by 24 h post-pneumococci injection. The exudate in the vitreous was predominantly mononuclear. Many gram-positive diplococci were present. By 48 h the inflammation was more severe, especially in the left eyes.
More mononuclear cells than PMN were present.
Growth of pneumococci in vitreous humor in vitro. Pneumococci multiplied for at least 48 h in the vitreous humor aspirated from normal rabbit eyes (Fig. 2) . The small volume of vitreous fluid available precluded sampling at later intervals.
The survival of pneumococci in the vitreous humor removed 4 days after the eyes had been injected with meningococci is shown in Fig. 3 . The pneumococci did not multiply in uncentrifuged vitreous humor, and the number of viable organisms decreased over the 48-h observation period. The pneumococci appeared to survive in the centrifuged vitreous humor from these eyes, but failed to multiply.
The pneumococci were able to grow in vitreous humor that was removed 8 days after injection of viable meningococci (Fig. 4) However, some effect was noted as late as 9 days. The term "protection" is used to indicate failure of the pneumococci to multiply or survive in the eyes and does not imply absence of clinically or histologically evident ocular damage.
The type of nonspecific resistance that follows infection of immunization with intracellular pathogens (4, 5, 20, 23) and is mediated by "activated macrophages" (13, 20, 22) was probably not responsible for the resistance to pneumococcal infections in the right eyes of our rabbits. Pneumococci are not readily phagocytized by macrophages (26) , and macrophages were not predominant in the eyes when protection was maximal.
Cross-reacting antibody could theoretically have protected the rabbits against pneumococcal challenge. Miller et al. (15) and Bankneider (3) have reported cross-reactions between meningococci and unrelated organisms. Antibody is present in vitreous humor in rabbits injected with protein antigens (8), but we found antimeningococcal antibody in only two serum samples tested. In previous experiments, no antibody was found in vitreous or aqueous humors (18) . In any case, maximal protection occurs earlier than antibody could have been produced by ocular cells (4 days after meningococci injection). For the same reason, it is unlikely that antipneumococcal antibody would have had an effect, since protection was noted as early as 24 h after pneumococci injection. Only one rabbit had antipneumococcal antibody in its serum. Rowley (21) and Shilo (24) described nonspecific resistance to infection induced by lipopolysaccharides. The meningococcal lipopolysaccharides could have induced nonspecific resistance to the pneumococci. Another possibility is that a toxic product of the meningococci was bactericidal for pneumococci. The failure of pneumococci to survive in centrifuged vitreous humor from eyes previously injected with meningococci might support this hypothesis. However, we cannot assert that all inflammatory cells were removed from the vitreous samples. The abnormally high population values shown in Fig. 2 and 4 probably reflect the fact that separate pipettes were not used for each dilution step.
The maximal protective effect was noted when PMN were still present in large numbers in the vitreous (4 days). When inflammation had subsided (14 and 22 days), the protection was less pronounced. Rabbits treated with nitrogen mustard to reduce the numbers of circulating PMN showed no protective effect at 4 days. The mere presence of PMN in the right eye at the time of pneumococci challenge might explain, in part, the apparent destruction of the pneumococci. However, although many PMN were present in the left eye by 24 h postpneumococci injection, the organisms remained extracellular and were not eliminated. Neither extracellular nor intracellular organisms were seen in many right eyes. Increased phagocytosis and subsequent digestion of the ingested organisms could account for this.
C-reactive protein (CRP) is a substance found in serum during acute infections (2, 9, 14, 25) and after episodes of tissue damage (10) . It reacts with the C (somatic) polysaccharide of the pneumococcus and its appearance has been associated with leukocytosis. A similar substance, the Cx-reactive protein (CxRP) was found in rabbits (1, 11) and studied extensively (28, 29, 30, 31) . It has been shown to cross-react with human CRP (7). Recent evidence indicates that CRP enhances the phagocytosis of several bacterial species by human leukocytes (6, 12 ). CRP appears in serum before antibody can be demonstrated (25) .
Patterson et al. (16, 17) postulated that CRP might participate in the nonspecific resistance to infection induced by bacterial endotoxins. They also found that isolated CRP had antibacterial activity.
We might hypothesize that intravitreal injection of meningococci (into the right eyes) induced production of CxRP in addition to the (27) showed that CxRP was present in the aqueous humor of rabbits with uveitis induced by typhoid vaccine, streptococci, and staphylococci. CxRP appeared within 24 h, and titers were higher in the aqueous humor than in serum, suggesting that it was produced locally (within the eye). CxRP was not demonstrated 14 days after intravitreal injection of streptococci. We did not observe protection in rabbits challenged 14 
